Johnson & Johnson's Akeega is opening new fronts in prostate cancer treatment with a fresh FDA approval making it the first ...
Zacks Investment Research on MSN
FDA approves J&J's Akeega for expanded use in prostate cancer
Johnson & Johnson JNJ announced that the FDA approved its precision therapy, Akeega (niraparib and abiraterone acetate ...
A new treatment strategy tested by UCLA researchers could offer new hope for men whose prostate cancer has returned after initial treatment. This approach could also help delay the need for hormone ...
Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly.
The state of prostate cancer in the U.S. is not exactly great. Just take a look at the “Prostate cancer statistics, 2025” report from the American Cancer Society, published at the beginning of ...
Cliff Richard, 85, said in an interview with “Good Morning Britain” that he was diagnosed with prostate cancer in 2024 after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback